Phase I trial of AZD1775 (MK1775), a wee1 kinase inhibitor, in patients with refractory solid tumors.
Khanh Tu Do
No relevant relationships to disclose
Deborah Wilsker
No relevant relationships to disclose
Priya Balasubramanian
No relevant relationships to disclose
Jennifer Zlott
No relevant relationships to disclose
Woondong Jeong
No relevant relationships to disclose
Scott M Lawrence
No relevant relationships to disclose
Robert J. Kinders
No relevant relationships to disclose
Jerry Collins
No relevant relationships to disclose
Alice P. Chen
No relevant relationships to disclose
James H. Doroshow
No relevant relationships to disclose
Shivaani Kummar
No relevant relationships to disclose